Published :
Tables : 68
Figures : 48
Category : Healthcare
No. of Pages : 235
Report Code : HC-U3273
Continuous Renal Replacement Therapy Market is estimated to value over USD 1.34 billion by 2027 end with a CAGR of over 7.2% during the forecast period 2020 to 2027. Rising prevalence of congestive heart failure and acute renal failure is the prime factor driving the market growth. According to the data provided by the New England Journal of Medicine, 2009, acute kidney injury has over 55% of mortality rate, resulting in the usage of renal replacement therapy. Continuous renal replacement therapy (CRRT) is primarily used for treating AKI patients that are hemodynamically unstable as it offers efficient removal of solute and a better hemodynamic stability when compared to other techniques of dialysis. According to the data provided by Baxter,2015 the number of AKI patients across the world is predicted to reach over 1.6 million by 2020 from over 790,000 cases in 2009. Furthermore, as per the annual report of NxStage, 2013, over 190,000 acute kidney failure cases are registered in the United States alone. Moreover, as per the International Society of Nephrology, over 10% of patients hospitalised in the European Union have developed AKI with a high mortality rate. Such a high risk of AKI has significantly increased the continuous renal replacement therapy market demand. However, the high cost of CRRT is predicted to impede the market growth. Market Segmentation: By Product Dialysates & Replacement Fluids Systems Disposables By Modality Continuous Veno-Venous Hemofiltration Continuous Veno-Venous Hemodiafiltration Continuous Veno-Venous Hemodialysis Slow Continuous Ultrafiltration By Therapy Renal Care Non-Renal Care By End User Hospitals Dialysis Centers Others By Region North America Europe Asia-Pacific Latin America Middle East and Africa The market is classified into product, modality, therapy, end user and region. The product segment is categorised into dialysates and replacement fluids, systems and disposables. The replacement fluids and dialysates is anticipated to hold the largest continuous renal replacement therapy market share and this can be attributed to the rising need of these products during the CRRT processes along with technological advancements. The modality segment is divided into continuous veno-venous hemodiafiltration, continuous veno-venous hemofiltration, slow continuous ultrafiltration and continuous veno-venous haemodialysis. The CVVH segment is predicted to lead the market during the forecasted period owing to the higher acceptance of this modality amongst healthcare service providers due to the benefits offer by CCRT modalities. Regional Analysis: The Europe region is predicted to subjugate the market during the forecasted timeframe and this can credited to rising prevalence of AKI owing to the increasing geriatric population, high usage rate of this procedure and rising approvals for CRRT systems shall drive the market growth. Competitive Landscape: Some of the major players of the market are Baxter International Inc., Fresenius Medical Care AG & Co. KGAA, Nikkiso Co. Ltd., B. Braun, Nxstage Medical Inc., Asahi Kasei Medical Co. Ltd, Bellco S.R.L., Infomed SA. FutureWise Key Takeaways: Growth prospects SWOT analysis Key market trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global continuous renal replacement therapy market by product, by modality, by therapy, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Rising prevalence of congestive heart failure and acute renal failure is the prime factor driving the market growth. According to the data provided by the New England Journal of Medicine, 2009, acute kidney injury has over 55% of mortality rate, resulting in the usage of renal replacement therapy. Continuous renal replacement therapy (CRRT) is primarily used for treating AKI patients that are hemodynamically unstable as it offers efficient removal of solute and a better hemodynamic stability when compared to other techniques of dialysis.
According to the data provided by Baxter,2015 the number of AKI patients across the world is predicted to reach over 1.6 million by 2020 from over 790,000 cases in 2009. Furthermore, as per the annual report of NxStage, 2013, over 190,000 acute kidney failure cases are registered in the United States alone. Moreover, as per the International Society of Nephrology, over 10% of patients hospitalised in the European Union have developed AKI with a high mortality rate. Such a high risk of AKI has significantly increased the continuous renal replacement therapy market demand. However, the high cost of CRRT is predicted to impede the market growth.
Market Segmentation:
By Product
By Modality
By Therapy
By End User
By Region
The market is classified into product, modality, therapy, end user and region. The product segment is categorised into dialysates and replacement fluids, systems and disposables. The replacement fluids and dialysates is anticipated to hold the largest continuous renal replacement therapy market share and this can be attributed to the rising need of these products during the CRRT processes along with technological advancements. The modality segment is divided into continuous veno-venous hemodiafiltration, continuous veno-venous hemofiltration, slow continuous ultrafiltration and continuous veno-venous haemodialysis. The CVVH segment is predicted to lead the market during the forecasted period owing to the higher acceptance of this modality amongst healthcare service providers due to the benefits offer by CCRT modalities.
Regional Analysis:
The Europe region is predicted to subjugate the market during the forecasted timeframe and this can credited to rising prevalence of AKI owing to the increasing geriatric population, high usage rate of this procedure and rising approvals for CRRT systems shall drive the market growth.
Competitive Landscape:
Some of the major players of the market are Baxter International Inc., Fresenius Medical Care AG & Co. KGAA, Nikkiso Co. Ltd., B. Braun, Nxstage Medical Inc., Asahi Kasei Medical Co. Ltd, Bellco S.R.L., Infomed SA.
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2.Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1 Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Continuous Renal Replacement Therapy Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Dialysates & Replacement Fluids 7.2 Systems 7.3 Disposables 7.3.1 Hemo-Filters 7.3.2 Blood Sets 7.3.3 Other Disposables 8. Continuous Renal Replacement Therapy Market, By Modality Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 8.1 Continuous Veno-Venous Hemofiltration 8.2 Continuous Veno-Venous Hemodiafiltration 8.3 Continuous Veno-Venous Hemodialysis 8.4 Slow Continuous Ultrafiltration 9. Continuous Renal Replacement Therapy Market, By Therapy Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 9.1 Renal Care 9.2 Non-Renal Care 10. Continuous Renal Replacement Therapy Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 10.1 Hospitals 10.2 Dialysis Centers 10.3 Others 11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 11.2.1. U.S. 11.2.2. Canada 11.2.3. Mexico 11.2.4. Rest of North America 11.3 Market Size (USD Mn) Forecast for North America 2020-2027 12. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Regional Market Trends 12.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 12.3.1. Brazil 12.3.2. Venezuela 12.3.3. Argentina 12.3.4. Rest of Latin America 12.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 13. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5 Switzerland 13.2.6. Spain 13.2.7. Russia 13.2.8. Poland 13.2.9. Rest of Western Europe 13.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 14. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1 Introduction 14.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 14.2.1 Japan 14.2.2 China 14.2.3 Singapore 14.2.4 Korea 14.2.5 India 14.2.6 Australia and New Zealand 14.2.7 ASEAN 14.2.8 Rest of Asia Pacific 14.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 15. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 15.1 Introduction 15.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 15.2.1 UAE 15.2.2 South Africa 15.2.3 Egypt 15.2.4 Saudi Arabia 15.2.5 Rest of MEA 15.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 16.1 Baxter International Inc. 16.1.1. Company Overview (HQ, Business Segments, Employee Strength) 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2 Fresenius Medical Care AG & Co. KGAA 16.2.1. Company Overview (HQ, Business Segments, Employee Strength) 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3 Nikkiso Co. Ltd. 16.3.1. Company Overview (HQ, Business Segments, Employee Strength) 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4 B. Braun 16.4.1. Company Overview (HQ, Business Segments, Employee Strength) 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 Nxstage Medical Inc. 16.5.1. Company Overview (HQ, Business Segments, Employee Strength) 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 Asahi Kasei Medical Co. Ltd 16.6.1. Company Overview (HQ, Business Segments, Employee Strength) 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7 Bellco S.R.L. 16.7.1. Company Overview (HQ, Business Segments, Employee Strength) 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8 Infomed SA. 16.8.1. Company Overview (HQ, Business Segments, Employee Strength) 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 17. Impact of COVID-19 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations 18. Competitive Intelligence and Competitive Matrix 18.1 Competitive Intelligence 18.2 Competitive Matrix 19. Major Deals and Strategic Alliances Analysis 19.1 Joint ventures 19.2 Mergers and acquisitions 19.3 Licensing and partnerships 19.4 Technology Collaborations 19.5 Strategic Divestments 19.6 Market Entry Strategies 20. Relevant Case Studies and Latest News Updates 21. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics